Inhaled insulin available in Spain:
This article was originally published in Clinica
Most of Spain's three million diabetics can now opt to have the medical examination that should give them access to inhaled - rather than injected - insulin. From yesterday, Pfizer's Exubera became available in Spanish pharmacies, joining those in Germany, Ireland and the UK, Pfizer Espana told Clinica. The dry-powder delivery system is being provided under a full, national reimbursement regime, but only by prescription, following a medical examination: the technology will be barred to patients who have certain respiratory conditions and to children (the age threshold will be at the discretion of the physician, Clinica understands). Exubera received EU-wide market approval in January 2006.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.